CLL Monitoring, MRD Detection, Bone Marrow
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Confirming the presence or absence of minimal residual disease in patients with known chronic lymphocytic leukemia who are either postchemotherapy or post-bone marrow transplantation
Additional Tests Lists test(s) that are always performed, at an additional charge, with the initial test(s)
|Test ID||Reporting Name||Available Separately||Always Performed|
|FCINT||Flow Cytometry Interp, 2-8 Markers||No, (Bill Only)||Yes|
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
When this test is ordered, flow cytometry interpretation, 2 to 8 markers will always be performed at an additional charge.
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
CLL Monitoring, MRD Detection, BM